(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.86% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.94%.
Aptargroup's revenue in 2025 is $3,554,747,000.On average, 4 Wall Street analysts forecast ATR's revenue for 2025 to be $243,951,693,090, with the lowest ATR revenue forecast at $240,701,169,984, and the highest ATR revenue forecast at $246,906,353,874. On average, 4 Wall Street analysts forecast ATR's revenue for 2026 to be $259,098,919,435, with the lowest ATR revenue forecast at $255,590,045,122, and the highest ATR revenue forecast at $265,318,500,198.
In 2027, ATR is forecast to generate $270,911,486,826 in revenue, with the lowest revenue forecast at $270,879,126,885 and the highest revenue forecast at $270,943,846,768.